Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 1966New England Journal of Medicine

Treatment of Hemophilia with Glycine-Precipitated Factor VIII

View Full Paper
Ask AI
Bookmark
Share

Authors

CACharles F. AbildgaardBaptist Memorial HospitalJSJoseph V. SimoneNew York Institute of TechnologyJCJames J. CorriganUniversity of Arizona

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Abildgaard et al. (1966) studied this question.

synapsesocial.com/papers/6a7e7ed7ac06d68e91cd9ad7https://doi.org/10.1056/nejm196609012750904
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The <i>in vivo</i> Longevity of Antihaemophilic Factor (Factor VIII)1964 · 32 citations
  2. 2Production of High-Potency Concentrates of Antihemophilic Globulin in a Closed-Bag System1965 · 428 citations
  3. 3Treatment of Classic Hemophilia: The Use of Fibrinogen Rich in Factor VIII for Hemorrhage and for Surgery1961 · 66 citations